258 related articles for article (PubMed ID: 19527805)
21. [With which extracorporeal treatments: convection versus diffusion].
Gonella M
G Ital Nefrol; 2008; 25 Suppl 41():S27. PubMed ID: 18473317
[No Abstract] [Full Text] [Related]
22. Blood purification therapy in treatment of acute renal failure in infants with melamine-induced stones.
Shen Y; Liu XR; Zhang GJ; Zhou N
Chin Med J (Engl); 2009 Feb; 122(3):257-61. PubMed ID: 19236800
[TBL] [Abstract][Full Text] [Related]
23. Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study.
Dominik A; Stange J; Pfensig C; Borufka L; Weiss-Reining H; Eggert M
Ther Apher Dial; 2014 Aug; 18(4):347-52. PubMed ID: 24215331
[TBL] [Abstract][Full Text] [Related]
24. 2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis.
;
Ther Apher Dial; 2010 Dec; 14(6):489-504. PubMed ID: 21118358
[TBL] [Abstract][Full Text] [Related]
25. Drugs in liver disease and during albumin dialysis -MARS.
Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B
Z Gastroenterol; 2001 Jun; 39 Suppl 2():33-5. PubMed ID: 16215894
[No Abstract] [Full Text] [Related]
26. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
27. Acute PD: Evidence, Guidelines, and Controversies
Ponce D; Balbi A; Cullis B
Semin Nephrol; 2017 Jan; 37(1):103-112. PubMed ID: 28153190
[TBL] [Abstract][Full Text] [Related]
28. [Kidney and liver support therapies: state-of-the-art methods].
Roy T; Vienken J; Wabel P
Biomed Tech (Berl); 2009 Oct; 54(5):245-54. PubMed ID: 19807288
[TBL] [Abstract][Full Text] [Related]
29. Beyond dialysis: current and emerging blood purification techniques.
Stegmayr B; Ramlow W; Balogun RA
Semin Dial; 2012; 25(2):207-13. PubMed ID: 22428812
[TBL] [Abstract][Full Text] [Related]
30. High-volume peritoneal dialysis in acute kidney injury: indications and limitations.
Ponce D; Berbel MN; Regina de Goes C; Almeida CT; Balbi AL
Clin J Am Soc Nephrol; 2012 Jun; 7(6):887-94. PubMed ID: 22461532
[TBL] [Abstract][Full Text] [Related]
31. Ability of a novel system for neonatal extracorporeal renal replacement therapy with an ultra-small volume circuit to remove solutes in vitro.
Nishimi S; Ishikawa K; Sasaki M; Furukawa H; Takada A; Chida S
Pediatr Nephrol; 2016 Mar; 31(3):493-500. PubMed ID: 26493070
[TBL] [Abstract][Full Text] [Related]
32. Advances and innovations in dialysis in the 21st century.
Power A; Duncan N; Goodlad C
Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: a single-center study.
Jung YS; Lee J; Shin HS; Rim H
Hemodial Int; 2012 Oct; 16(4):456-64. PubMed ID: 22541135
[TBL] [Abstract][Full Text] [Related]
34. Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal.
Winchester JF; Silberzweig J; Ronco C; Kuntsevich V; Levine D; Parker T; Kellum JA; Salsberg JA; Quartararo P; Levin NW
Blood Purif; 2004; 22(1):73-7. PubMed ID: 14732814
[TBL] [Abstract][Full Text] [Related]
35. New insights in end-stage renal disease therapies: from dialysis to apheresis by means of membrane characteristics.
Santoro A
Blood Purif; 2013; 35 Suppl 2():28-9. PubMed ID: 23676833
[No Abstract] [Full Text] [Related]
36. Peritoneal membrane structural and functional changes during peritoneal dialysis.
Goffin E
Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
[TBL] [Abstract][Full Text] [Related]
37. Albumin dialysis and plasma filtration adsorption dialysis system.
Nalesso F; Brendolan A; Crepaldi C; Cruz D; de Cal M; Bellomo R; Ronco C
Contrib Nephrol; 2007; 156():411-8. PubMed ID: 17464152
[TBL] [Abstract][Full Text] [Related]
38. [New methods for extrarenal purification of the blood].
Patev E
Vutr Boles; 1980; 19(4):8-4. PubMed ID: 6998134
[No Abstract] [Full Text] [Related]
39. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
